Cardia Bioplastics (ASX:CNN) Cash-to-Debt : 5.32 (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Cardia Bioplastics Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Cardia Bioplastics's cash to debt ratio for the quarter that ended in Dec. 2023 was 5.32.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Cardia Bioplastics could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Cardia Bioplastics's Cash-to-Debt or its related term are showing as below:

ASX:CNN' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.14 Med: 1.61 Max: No Debt
Current: 5.32

During the past 13 years, Cardia Bioplastics's highest Cash to Debt Ratio was No Debt. The lowest was 0.14. And the median was 1.61.

ASX:CNN's Cash-to-Debt is ranked better than
83.16% of 380 companies
in the Packaging & Containers industry
Industry Median: 0.4 vs ASX:CNN: 5.32

Cardia Bioplastics Cash-to-Debt Historical Data

The historical data trend for Cardia Bioplastics's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Cardia Bioplastics Cash-to-Debt Chart

Cardia Bioplastics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Cash-to-Debt

Get a 7-Day Free Trial

2.01

1.50

5.27

1.73

4.58

Cardia Bioplastics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															3.76	1.73	1.94	4.58	5.32

Competitive Comparison of Cardia Bioplastics's Cash-to-Debt

For the Packaging & Containers subindustry, Cardia Bioplastics's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cardia Bioplastics's Cash-to-Debt Distribution in the Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Cardia Bioplastics's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Cardia Bioplastics's Cash-to-Debt falls into.

Cardia Bioplastics Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Cardia Bioplastics's Cash to Debt Ratio for the fiscal year that ended in Jun. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	8.424	/	(0.78	+	1.061)
	=	4.58

Cardia Bioplastics's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	7.445	/	(0.585	+	0.815)
	=	5.32

Cardia Bioplastics (ASX:CNN) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Cardia Bioplastics Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Cardia Bioplastics's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardia Bioplastics (ASX:CNN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Cardia Bioplastics Ltd (ASX:CNN) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

SES:Australia

Address

247 Ferntree Gully Road, Unit 1, Mount Waverley, Melbourne, VIC, AUS, VIC 3149

Website

https://www.secosgroup.com.au

SECOS Group Ltd is an Australian developer and manufacturer of sustainable packaging materials. . Business operating segment includes the manufacture and distribution of polyethylene films, renewable resource-based resins, and finished products. It supplies proprietary biodegradable resins, packaging products cast films to a customer base spread globally.SECOS Global Application Development Centre is in Australia. Product Development Centre and manufacturing plant for resins and finished products in China and resins plant in Malaysia. It also has manufacturing plants for cast films in Malaysia. It conducts sales via geographical regions that include Australia, Asia, America, Europe, and Africa. Asia generates maximum revenue for the company.

Cardia Bioplastics (ASX:CNN) Headlines

No Headlines